New Independent Directors Appointed by Syneos

Syneos Health has announced that it has appointed Barbara W. Bodem and Alfonso G. Zulueta to its Board of Directors. The two new independent directors bring their insights to help the company’s customers get their therapeutics to patients. Bodem was the Senior Vice President and Chief Financial Officer at Hillrom and currently is a member of the board of directors of Turning Point Therapeutics.

According to their press release, “Mr. Zulueta has over three decades of experience in global strategic and leadership roles within large pharma, specifically with Eli Lilly and Company. At Eli Lilly, he held key senior positions including Vice President of Global Marketing, President of Global Oncology and Critical Care Products, and most recently as President of International responsible for all geographies outside the United States and Canada from 2017 until his retirement at the end of 2021.”

Learn more about the new directors by clicking here.

(Source: Syneos Health, January 18^th, 2022)